Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: https://doi.org/10.21256/zhaw-1687
Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments
Autor/-in: Lanz, Jan
Riedl, Rainer
DOI: 10.1002/cmdc.201402478
10.21256/zhaw-1687
Erschienen in: ChemMedChem
Band(Heft): 10
Heft: 3
Seite(n): 451
Seiten bis: 454
Erscheinungsdatum: 2015
Verlag / Hrsg. Institution: Wiley
ISSN: 1860-7187
1860-7179
Sprache: Englisch
Schlagwörter: Medicinal chemistry; De novo drug design
Fachgebiet (DDC): 572: Biochemie
615: Pharmakologie und Therapeutik
Zusammenfassung: The de novo design of molecules from scratch with tailored biological activity is still the major intellectual challenge in chemical biology and drug discovery. Herein we validate natural-product-derived fragments (NPDFs) as excellent molecular seeds for the targeted de novo discovery of lead structures for the modulation of therapeutically relevant proteins. The application of this de novo approach delivered, in synergy with the combination of allosteric and active site binding motifs, highly selective and ligand-efficient non-zinc-binding (3: 4-{[5-(2-{[(3-methoxyphenyl)methyl]carbamoyl}eth-1-yn-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}benzoic acid) as well as zinc-binding (4: 4-({5-[2-({[3-(3-carboxypropoxy)phenyl]methyl}carbamoyl)eth-1-yn-1-yl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)benzoic acid) uracil-based MMP-13 inhibitors presenting IC50 values of 11 nM (3: LE=0.35) and 6 nM (4: LE=0.31).
Weitere Angaben: Coverpicture: https://doi.org/10.1002/cmdc.201590003
URI: https://digitalcollection.zhaw.ch/handle/11475/2862
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): CC BY-NC-ND 4.0: Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International
Departement: Life Sciences und Facility Management
Enthalten in den Sammlungen:Publikationen Life Sciences und Facility Management

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
2015_Lanz_Merging allosteric and active site binding motifs_ChemMedChem.pdf726.94 kBAdobe PDFMiniaturbild
Öffnen/Anzeigen
Zur Langanzeige
Lanz, J., & Riedl, R. (2015). Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments. ChemMedChem, 10(3), 451–454. https://doi.org/10.1002/cmdc.201402478
Lanz, J. and Riedl, R. (2015) ‘Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments’, ChemMedChem, 10(3), pp. 451–454. Available at: https://doi.org/10.1002/cmdc.201402478.
J. Lanz and R. Riedl, “Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments,” ChemMedChem, vol. 10, no. 3, pp. 451–454, 2015, doi: 10.1002/cmdc.201402478.
LANZ, Jan und Rainer RIEDL, 2015. Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural-product-derived fragments. ChemMedChem. 2015. Bd. 10, Nr. 3, S. 451–454. DOI 10.1002/cmdc.201402478
Lanz, Jan, and Rainer Riedl. 2015. “Merging Allosteric and Active Site Binding Motifs : De Novo Generation of Target Selectivity and Potency via Natural-Product-Derived Fragments.” ChemMedChem 10 (3): 451–54. https://doi.org/10.1002/cmdc.201402478.
Lanz, Jan, and Rainer Riedl. “Merging Allosteric and Active Site Binding Motifs : De Novo Generation of Target Selectivity and Potency via Natural-Product-Derived Fragments.” ChemMedChem, vol. 10, no. 3, 2015, pp. 451–54, https://doi.org/10.1002/cmdc.201402478.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.